secukinumab

BASEL, Switzerland, June 1, 2026 Novartis announced that it will present new data from 31 abstracts across its expanding...

BASEL, Switzerland, March 13, 2026 Global pharmaceutical leader Novartis has announced that the U.S. Food and Drug Administration (FDA)...